Health Enhancement
Products, a health and wellness company developing natural bioactive compounds
for use as dietary supplements and food ingredients, as well as biologics for
medicinal and pharmaceutical applications in humans and animals, reports that
it has entered into a collaborative/option agreement with a global animal
health company. For competitive considerations and to protect the intellectual
property of both parties, the name of the animal health company is being
withheld.
HEPI will
collaborate with scientists from the animal health company to move forward with
validation and product development. The agreement provides for a licensing
option covering bovine applications across a range of modalities, and includes
HEPI’s natural compound, the company’s proprietary refined algal extract and
the synthetic molecules.
Additional terms of
the agreement call for pre-determined intervals of 90 days for an evaluation
period and a negotiation period, which HEPI expects may result in a final
licensing arrangement.
HEPI says that
additional details may be released over the next few weeks.
For more information
visit http://health-enhancement-products.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment